US 6713066
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
expired A61KA61K2039/5254A61K39/00
Quick answer
US patent 6713066 (Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 63
- CPC classes
- A61K, A61K2039/5254, A61K39/00